Mark J. Mullin

MedicinePharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “A Phase 1 Study to Evaluate the Absorption, Metabolism, and Disposition of Dordaviprone in Healthy Adult Participants”.

A Phase 1 Study to Evaluate the Absorption, Metabolism, and Disposition of Dordaviprone in Healthy Adult Participants

Clinical Pharmacology in Drug Development(2025)10.1002/cpdd.1541

N/A

0.241DataRank · unranked

4 citations

Tim Tippin, Angela Bartkus, Francine A. de Castro, Shamia L. Faison, Marion Morrison +3 more

Quantitation of the next-generation imipridone ONC206 in human plasma by a simple and sensitive UPLC-MS/MS assay for clinical pharmacokinetic application

Journal of Pharmaceutical and Biomedical Analysis(2022)10.1016/j.jpba.2022.114685

N/A

0DataRank · unranked

7 citations

Sara Zimmerman, Cody J. Peer, Varun V. Prabhu, Tyler Yin, William J. Richardson +7 more